Aethlon Medical, Inc. AEMD 深 滬
已收盤 02-06 16:00:00 美东时间
2.23
+0.090
+4.21%
華盛通- 最 高2.30
- 今 開2.10
- 成交量 4.55万股
- 最 低 2.08
- 昨 收 2.14
- 總市值 217.03万
- 52周最高 53.272
- 市盈率 靜 --
- 換手率 4.67%
- 52周最低 2.08
- 委 比 -20.53%
- 總股本 97.32万
- 歷史最高 432000.00
- 量 比 1.33
- 振 幅 10.28%
- 歷史最低 2.08
- 每 手 1
- 風險率 14.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aethlon Medical Files For Common Stock Offering Of $15M
$15,000,000 Common Stock From time to time, we may offer and sell shares of our common stock, par value $0.001 per share, with total gross proceeds of up to $15,000,000. This prospectus provides a general
2025-12-24 04:10
Aethlon Medical Announces Publication Of Pre-Clinical Long COVID Study On bioRxiv
Results Support the Further Investigation of the Hemopurifier in Long COVIDSAN DIEGO, Dec. 2, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to
2025-12-02 21:26
Aethlon Medical shares are trading higher. The company reported Q2 financial results.
Aethlon Medical shares are trading higher. The company reported Q2 financial re...
2025-11-13 22:15
Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(3.74) per share which missed the analyst consensus estimate of $(3.66) by 2.1 percent. This is a 133.75 percent decrease over losses of $(1.60) per share from
2025-11-13 05:16
Aethlon Medical Regains Nasdaq Compliance
On November 5, 2025, Aethlon Medical, Inc., a Nevada corporation (the "Company") received a letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it
2025-11-06 22:22
Aethlon Medical Faces Nasdaq Non-Compliance Notice
Aethlon Medical ( ($AEMD) ) has provided an update. On October 16, 2025, Aethlo...
2025-10-23 04:57
Aethlon Medical Reports Early Signals From Hemopurifier Trial In Cancer Patients, Showing Immune And Molecular Shifts In First Cohort
Aethlon Medical, Inc. ("Aethlon" or the "Company") (NASDAQ:AEMD) today provided observations on the preliminary changes in extracellular vesicle (EV), microRNA and lymphocyte counts in the first patient cohort in its
2025-10-07 20:13
Aethlon Medical Completes $4.5 Million Public Offering
Aethlon Medical ( ($AEMD) ) has shared an announcement. On September 4, 2025, A...
2025-09-10 04:28
Aethlon Medical shares are trading lower after the company announced a $4.5 million public offering.
Aethlon Medical shares are trading lower after the company announced a $4.5 mil...
2025-09-04 23:13
